01 — At a Glance
The Chemistry is Complicated. Literally.
- 52-Week High / Low₹2,174 / ₹1,436
- TTM Sales₹7,946 Cr
- TTM PAT₹533 Cr
- Full-Year EPS (FY25)₹51.12
- Annualised EPS (Q3×4)₹29.28
- Book Value₹404
- Price to Book3.69x
- Dividend Yield0.50%
- Debt / Equity0.23x
- Net Worth (Sep 25)₹5,651 Cr
Auditor’s Opening Note: Deepak Nitrite posted Q3 FY26 consolidated revenue of ₹1,983 crore (+3% YoY), but EPS annualised at ₹29.28 vs FY25’s ₹51.12 — a 43% cliff. ROCE is a healthy 16.3% but trending downward. The company is burning cash on ₹2,500 crore FY27 capex while integration projects struggle to deliver margin accretion. Current P/E of 37.5x prices in either genius or delusion. Management swears it’s the former. Charts suggest middle ground.
02 — Introduction
Welcome to Capex Hell, Where Genius Meets Execution Risk
Deepak Nitrite was incorporated in 1970, has never had a year where it wasn’t profitable, manufactures chemicals that nobody at parties understands, yet somehow the stock rallied 37% over 10 years while actual profit growth was 29%. Translation: Mr. Market loved the trajectory more than the destination.
The company operates two segments: Phenolics (think phenol, acetone, isopropyl alcohol — the stuff that makes your life pleasant if you work in construction, pharma, or explosives) and Advanced Intermediates (sodium nitrite, xylidines, color intermediates — the stuff China is dumping at cutthroat prices). FY25 was stellar. FY26 is purgatory. Why?
Because the company bet ₹2,400 crore on vertical integration — nitric acid, nitration, hydrogenation plants all coming online simultaneously. The strategic logic is pristine. The execution timing was catastrophic. They commissioned nitration in Jan 2026 but couldn’t source internal nitric acid until mid-December 2025, forcing them to buy spot rates and obliterate margins. Advanced Intermediates EBIT dropped 88% YoY despite revenue up 18%. That’s not cyclicality. That’s self-sabotage wearing a strategic mask.
Add to this: ₹11,000 crore earmarked for a polycarbonate mega-plant (India’s first integrated propylene-to-polycarbonate chain), expected delivery Dec 2027. Meanwhile, Advanced Intermediates are getting obliterated by Chinese oversupply, debt ratios are rising, and management keeps saying “wait for Q4 and Q1 FY27 to see integration upside.” Investors hate waiting. Markets love volatility. This stock is a masterclass in both.
Concall Verbatim (Feb 2026): “We prioritized market presence even if it comes at the expense of having to procure raw materials like nitric acid at spot rates… Q3 looked much weaker.” Translation: We sacrificed ₹80+ crore in margin to avoid losing market share to cheaper imported crap.
03 — Business Model: Chemical Intermediates That Don’t Excite Dinner Conversations
Making Stuff That Makes Other Stuff. Recursively.
Phenolics (70% of revenue, 84% domestic): Deepak Nitrite is India’s largest producer of Phenol and Acetone. 50%+ market share. The company operates a plant that produces ~350,000 tonnes of phenol annually (a milestone of 2 million tonnes cumulatively in Q3 FY26). Phenol goes into plywood, auto parts, pharmaceuticals, adhesives. Acetone is basically the cleaning fluid that makes everything possible. High volume, high margin, stable. FY26 Q3 revenue ₹1,334 crore, EBIT ₹145 crore (+20% YoY). No innovation needed. Just utilization and operational efficiency. Management nailed this.
Advanced Intermediates (30% of revenue, but 50-50 domestic-export): Sodium nitrite (largest producer in India, top 5 globally). Xylidines, oximes, color intermediates, OBAs, DASDA. Serve dyes, rubber, agrochemicals, pharma, water treatment. Q3 FY26 revenue ₹652 crore (+18% YoY) but EBIT tanked to ₹15 crore from ₹95 crore last year. Why? Chinese producers dumping commodity nitrites and xylidines at 30-40% below previous years. Deepak Nitrite chose to absorb margin pain rather than lose volume. Tactically correct (market share). Financially catastrophic (Q3 PAT crashed 74%).
New products pipeline: 15 products in various stages. Mining chemicals, flame retardants, polymer applications, flavors & fragrances. Most at pilot scale, awaiting customer approvals. Commercialization “in a staggered manner over next several months into FY27.” Translation: Optimistic but non-material for another 6-12 months.
Phenol50%+Market Share
Sodium NitriteLargestIn India
Phenol Output350 KTPACapacity
Domestic Mix84%FY26 Revenue
The Integration Bet: Nitric acid plant (₹515 crore capex) commissioned Dec 4, 2025. Nitration plant commissioned Jan 19, 2026. Why? Vertical integration removes supplier dependency (external nitric acid costs were killing margins). Once 100% internal consumption kicks in Q4 & Q1, margins should recover structurally. This is the thesis. The execution was sloppy. The comeback bet is real.
💬 If integration is supposed to be so good, why didn’t they commission nitric acid before nitration? Efficiency or just luck-of-the-draw project management?
04 — Financials Overview
Q3 FY26: The Numbers That Explain The Stock’s Malaise
Result type: Quarterly Results | Q3 FY26 EPS: ₹7.32 | Annualised EPS (Q3×4): ₹29.28 | Full-year FY25 EPS: ₹51.12
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 1,975 | 1,903 | 1,902 | +3.76% | +3.83% |
| Operating Profit (EBIT) | 211 | 169 | 204 | +24.9% | +3.4% |
| EBIT Margin % | 11% | 9% | 11% | +200 bps | flat |
| PAT | 100 | 98 | 119 | +2.0% | -15.9% |
| EPS (₹) | 7.32 | 7.19 | 8.70 | +1.8% | -15.8% |
🚨 Critical Caveat: Q3 FY26 PAT includes a one-time exceptional provision of ₹12.84 crore for new labour codes (basically a regulatory surprise). Adjust for this and organic PAT is ~₹112-113 crore, which is still down 13% YoY due to Advanced Intermediates margin compression. EBIT growth looks healthy (+24.9%) because Phenolics (+20% EBIT) offset AI’s (-88% EBIT) disaster. But that’s cosmetics. The underlying story is two business segments on divergent trajectories.
05 — Valuation Discussion: Fair Value Range
Is This a Genius-Level Integration Play or a Capex Trap?
Join 10,000+ investors who read this every week.
